Trelegy Ellipta

Showing 2 posts of 2 posts found.

GSK gets EU go-ahead for triple therapy inhaler in COPD

November 16, 2017
Sales and Marketing COPD, FDA, GSK, Trelegy Ellipta, pharma

The EMA has awarded EU marketing authorisation to GlaxoSmithKline and Innovia’s single inhaler triple therapy Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for …

gsk_hq_close

GSK gets FDA approval for key triple therapy inhaler

September 20, 2017
Research and Development, Sales and Marketing GSK, Trelegy Ellipta, biotech, drugs, pharma, pharmaceutical

The good news keeps on rolling in for GSK, with the FDA approval for its triple therapy inhaler.

Latest content